Evidence map›Paper›PMID 17985214›Full record

ArticleTransgenic research2007

Biologically active human GM-CSF produced in the seeds of transgenic rice plants.

Ravinder Sardana, Anil K Dudani, Eilleen Tackaberry, Zaman Alli, Suzanne Porter, Karen Rowlandson, Peter Ganz, Illimar Altosaar

Abstract read
PubMed Publisher
In one paragraph

Article in Transgenic research, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Plant Based Bioreactors of Recombinant Cytokines (Review).Applied biochemistry and microbiology · 2016
    Review
  3. Improving pharmaceutical protein production in Oryza sativa.International journal of molecular sciences · 2013
    Review
  4. Article
  5. Recombinant cytokines from plants.International journal of molecular sciences · 2011
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ravinder SardanaDepartment of Biochemistry, Microbiology & Immunology, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON, Canada, K1H 8M5.
Anil K Dudani
Eilleen Tackaberry
Zaman Alli
Suzanne Porter
Karen Rowlandson
Peter Ganz
Illimar Altosaar
University of Ottawa · CAHealth Canada · CAInnovation, Science and Economic Development Canada · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rice flour is a well-known and characterized source of pharmaceutical ingredients, which are gluten-free and incorporated in many drug delivery applications such as excipient starch. To further exploit this uniqueness, the synthetic capacity of rice endosperm tissue, the basis of rice flour, was extended by genetic transformation. Recombinant human GM-CSF, a cytokine used in treating neutropenia and with other potential clinical applications, has been expressed in transgenic rice seeds using a rice glutelin promoter. Rice seeds accumulated human GM-CSF to a level of 1.3% of total soluble protein. The rice seed-produced human GM-CSF was found to be biologically active when tested using a human cell line TF-1. Use of rice as a host plant offers not only attractive features of safe production in seeds but also self-containment of foreign genes, as rice is primarily a self-pollinated crop plant.

Indexed as

Plants, Genetically ModifiedCell LineGlutensGranulocyte-Macrophage Colony-Stimulating FactorHumansOryzaPromoter Regions, GeneticRecombinant ProteinsRhizobiumSeedsGlutensGranulocyte-Macrophage Colony-Stimulating FactorRecombinant Proteins

Identifiers

PMID17985214
OpenAlexW2071024417

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.